Inovio Pharmaceuticals (INO) Surged To A 7-Month High On HIV Study Results

Inovio Pharmaceuticals (INO) announced Wednesday that its HIV vaccine, PENNVAX-GP, produced amongst the highest overall levels of immune response rates ever demonstrated in a human study.

from RTT - Before the Bell http://ift.tt/2qZpl07
via IFTTT